Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lindsay Devane

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Pharmacotherapy|November 11, 2014
Basic science and the Ebola virus infection epidemicC Lindsay DeVane
Pharmacotherapy|January 15, 2019
Pharmacotherapy Rounds: When Old Drugs Require New GuidelinesC Lindsay DeVane
Pharmacotherapy|February 7, 2013
What evidence is required for drug exposure to be causally associated with adverse events? The case for case reports published in PharmacotherapyC Lindsay DeVane
Pharmacotherapy|November 25, 2015
The Art and Science of Reviewing the Pharmacotherapy LiteratureC Lindsay DeVane
Pharmacotherapy|July 21, 2017
Opioid Use and Abuse and Neonatal Abstinence SyndromeC Lindsay DeVane
Pharmacotherapy|December 21, 2016
Pharmacotherapy: Cover Story and UpdatesC Lindsay DeVane
Pharmacotherapy|February 14, 2014
Essential tools for designing pharmacotherapyC Lindsay DeVane
Pharmacotherapy|January 11, 2020
Critical Appraisals of Cannabis and Related Compounds in PharmacotherapyC Lindsay DeVane
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 19, 2006
Antidepressant-drug interactions are potentially but rarely clinically significantC Lindsay DeVane
The Journal of Clinical Psychiatry|January 1, 2004
Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nauseaC Lindsay DeVane
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Pharmacotherapy|November 11, 2014
Basic science and the Ebola virus infection epidemicC Lindsay DeVane
Pharmacotherapy|January 15, 2019
Pharmacotherapy Rounds: When Old Drugs Require New GuidelinesC Lindsay DeVane
Pharmacotherapy|February 7, 2013
What evidence is required for drug exposure to be causally associated with adverse events? The case for case reports published in PharmacotherapyC Lindsay DeVane
Pharmacotherapy|November 25, 2015
The Art and Science of Reviewing the Pharmacotherapy LiteratureC Lindsay DeVane
Pharmacotherapy|July 21, 2017
Opioid Use and Abuse and Neonatal Abstinence SyndromeC Lindsay DeVane
Pharmacotherapy|December 21, 2016
Pharmacotherapy: Cover Story and UpdatesC Lindsay DeVane
Pharmacotherapy|February 14, 2014
Essential tools for designing pharmacotherapyC Lindsay DeVane
Pharmacotherapy|January 11, 2020
Critical Appraisals of Cannabis and Related Compounds in PharmacotherapyC Lindsay DeVane
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 19, 2006
Antidepressant-drug interactions are potentially but rarely clinically significantC Lindsay DeVane
The Journal of Clinical Psychiatry|January 1, 2004
Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nauseaC Lindsay DeVane
Pageof 10